ETHOSUXIMIDE
- Product NDC
- 62135-790
- 11-digit product format
- 621350790
- Labeler code
- 62135
- Product ID
- 62135-790_24119078-bcee-0aa9-e063-6394a90af9c8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ETHOSUXIMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA200892
- Marketing category
- ANDA
- Marketing start
- 2015-09-09
- Substance
- ETHOSUXIMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ETHOSUXIMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETHOSUXIMIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5SEH9X1D1D |
| Rxcui | 197682 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-790-12 | ETHOSUXIMIDE | 120 in 1 BOTTLE | CAPSULE | 120 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-790 | ETHOSUXIMIDE CAPSULE [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241011_43fdfd16-c723-452a-9c1d-accf6f7c622e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-790-12 | 62135079012 | 120 CAPSULE in 1 BOTTLE (62135-790-12) | 120 capsule | 2023-10-23 | No | No | Historical |